These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6469439)
1. Safety of flurbiprofen in subjects with G-6-PD deficiency. In vivo and in vitro results. Passiu G; Mela Q; Perpignano G; Frigerio R; Cacace E Int J Clin Pharmacol Res; 1984; 4(2):137-9. PubMed ID: 6469439 [TBL] [Abstract][Full Text] [Related]
2. Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiency. Perpignano G; Mela Q; Ruggiero V; Pitzus F Drugs Exp Clin Res; 1990; 16(12):635-8. PubMed ID: 2130006 [TBL] [Abstract][Full Text] [Related]
3. Irradiation shortens the survival time of red cells deficient in glucose-6-phosphate dehydrogenase. Westerman MP; Wald N; Diloy-Puray M Radiat Res; 1980 Mar; 81(3):473-7. PubMed ID: 7360895 [No Abstract] [Full Text] [Related]
4. Tolmetin and G-6-PD erythrocyte deficiency: research in vitro. Passiu G; Piras MG; Perpignano G; Ibba G; Carcassi U J Int Med Res; 1979; 7(5):351-3. PubMed ID: 499642 [TBL] [Abstract][Full Text] [Related]
5. [Endoscopic and histological study of the gastric injury effects of an anti-inflammatory derivative, flurbiprofen (Froben)]. Celli L; Mazzeo F; Bertuglia L; Granelli P Minerva Dietol Gastroenterol; 1979; 25(4):385-90. PubMed ID: 554029 [No Abstract] [Full Text] [Related]
6. [Double-blind controlled comparison of placebo and paracetamol in patients with G-6-PD deficiency]. Cottafava F; Nieri S; Franzone G; Sanguinetti M; Bertolazzi L; Ravera G Pediatr Med Chir; 1990; 12(6):631-7. PubMed ID: 2093885 [TBL] [Abstract][Full Text] [Related]
7. The influence of G-6-PD activity on the response of erythrocyte glutathione reductase to riboflavin deficiency. Prentice AM; Bates CJ; Prentice A; Welch SG; Williams K; McGregor IA Int J Vitam Nutr Res; 1981; 51(3):211-5. PubMed ID: 7319720 [TBL] [Abstract][Full Text] [Related]
8. High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency. Johnson GJ; Vatassery GT; Finkel B; Allen DW N Engl J Med; 1983 Apr; 308(17):1014-7. PubMed ID: 6835308 [No Abstract] [Full Text] [Related]
9. Reduced chronic hemolysis in Mediterranean glucose-6-phosphate dehydrogenase deficiency after vitamin E therapy. Schulman JD; Corash L; Bartsocas C; Spielberg S; Boxer L; Sheetz M; Steinherz R; Papadatos C Prog Clin Biol Res; 1979; 34():381-7. PubMed ID: 531063 [No Abstract] [Full Text] [Related]
10. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Galasko DR; Graff-Radford N; May S; Hendrix S; Cottrell BA; Sagi SA; Mather G; Laughlin M; Zavitz KH; Swabb E; Golde TE; Murphy MP; Koo EH Alzheimer Dis Assoc Disord; 2007; 21(4):292-9. PubMed ID: 18090435 [TBL] [Abstract][Full Text] [Related]
11. [Erythrocyte survival in patients with G6PD deficiency during administration of suprofen]. Passiu G; Mela Q; Perpignano G; Carcassi U Boll Chim Farm; 1984 Aug; 123(8):61S-64S. PubMed ID: 6525252 [No Abstract] [Full Text] [Related]
12. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency. Ali NA; al-Naama LM; Khalid LO East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824 [TBL] [Abstract][Full Text] [Related]
13. The haemolytic effect of a single dose of 45 mg of primaquine in G-6-PD deficient Thais. Charoenlarp P; Areekul S; Harinasuta T; Sirivorasarn P J Med Assoc Thai; 1972 Nov; 55(11):631-8. PubMed ID: 4566625 [No Abstract] [Full Text] [Related]
14. [Procetofen: hemolytic effect in subjects with G6PD deficiency. Description of a case]. Testa S; Nurra P; Nurra V Clin Ter; 1982 Sep; 102(5):519-22. PubMed ID: 7151373 [No Abstract] [Full Text] [Related]
15. The role of reduced glutathione during the course of acute haemolysis in glucose-6-phosphate dehydrogenase deficient patients: clinical and pharmacodynamic aspects. Corbucci GG Int J Clin Pharmacol Res; 1990; 10(5):305-10. PubMed ID: 1981880 [TBL] [Abstract][Full Text] [Related]
16. Blood-loss studies for new non-steroidal anti-inflammatory drugs. Mitchell H; Barraclough D; Muirden KD Med J Aust; 1982 Apr; 1(8):328. PubMed ID: 6979672 [No Abstract] [Full Text] [Related]
17. The course of primaquine-induced haemolysis in G-6-PD-deficient Thais. Charoenlarp P; Areekul S; Pholpothi T; Harinasuta T J Med Assoc Thai; 1973 Jul; 56(7):392-7. PubMed ID: 4805904 [No Abstract] [Full Text] [Related]
18. [Prevalence and incidence of glucose-6-phosphate dehydrogenase deficiency in the central region of Cuba]. Machado Cano M; Opol'skiĭ AF Genetika; 1984 May; 20(5):864-7. PubMed ID: 6539728 [TBL] [Abstract][Full Text] [Related]
19. Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs. Fraser IM; Tilton BE; Vesell ES Pharmacology; 1971; 5(3):173-87. PubMed ID: 5119006 [No Abstract] [Full Text] [Related]
20. Steroid-sparing action of flurbiprofen and indomethacin in rheumatoid arthritis: a nine-week study. Viara M; Benvenuti C; Longoni A Eur J Rheumatol Inflamm; 1983; 6(2):192-6. PubMed ID: 6673983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]